Solving complex problems in
Small Molecule and Biologics

Our dedicated team leverages microbial fermentation expertise and complex chemistry experience to support our partners’ product development and manufacturing from clinical to commercial stage. We care about your success!

Feature Story

Flexibility, creativity, and dedication to make better therapeutics are at the heart of what we do. Read more on recent updates and highlights around our contract drug manufacturing activities.

Event Post Thumbnail

BIOVECTRA Welcomes Normand Blais to Senior Director, Development & Innovation, Biologics Role

18 January 2023

  Charlottetown, P.E.I. (January 18, 2023) – BIOVECTRA is pleased to announce that Normand Blais was appointed as Senior Director, Development & Innovation, Biologics.  Reporting to the Chief Science Officer, Mr. Blais will be responsible for the strategic direction shaping BIOVECTRA’s pDNA & mRNA vaccine process science program. Mr. Blais is accomplished in early-candidate vaccine […]

Read More…

Read More

Synthetic Small Molecules

Our experience in a wide variety of complex chemistries allows us to offer you a tailored approach and phase-appropriate solutions for your API project.

Fermented Small Molecules

We offer robust microbial fermentation capabilities throughout your products life cycle from pilot to commercial scale.

Highly Potent APIs

With extensive HPAPI process development and production experience for small and large molecule APIs, we are here to advance your project.


With core expertise in complex microbial fermentation, we continue to add to our ability to accommodate small-batch, pilot, clinical, and commercial production needs.

Project Support

We are dedicated to producing quality products and effectively managing client projects by bringing process engineering, project management, quality, and regulatory expertise to all we do.


BIOVECTRA offers a selection of high-quality Bioreagents, available in a variety of package sizes as well as GMP grade, to support your project from research and testing to manufacturing scale operations.

Thought Leadership

Explore our educational resources! Whether it is our innovative approach to manufacturing biologics using microbial fermentation or insight into the risk management of capital expansions – it is good to know educational information is available. Our Thought Leadership page is the place to find whitepapers, brochures, webinars, and other materials to enhance your knowledge.

Come. Stay. Grow.

BIOVECTRA is a leading pharma and biotech CDMO seeking people of all skillsets, backgrounds and walks of life to join our diverse and growing team. Located in picturesque Prince Edward Island and Nova Scotia, our communities offer a safe and welcoming place for you to advance your career. 

Upcoming Events

Throughout the year, BIOVECTRA participates in a variety of tradeshows, industry conferences, scientific meetings, and other physical and virtual events. Check out our events page to learn more. We would love to catch up with you!

Event Post Thumbnail

Bio Digital

Join us virtually at Bio Digital from June 10-11 and 14-18. To set up a meeting with our team, use the contact form below. We look forward to connecting.
Read More

Oliver Technow - Chief Executive Officer

  • Industry Master Degree from Frankfurt Chamber of Commerce, Frankfurt Germany.
  • More than 20 years of global pharmaceutical industry experience.
  • Held numerous leadership positions in commercial development, marketing and brand management, and lifecycle management and has extensive product launch and market access expertise in Europe and North America.
  • In 1997, joined Eisai GmbH in Frankfurt, Germany and in 2002, was appointed Director, CNS Business Unit; in 2006, was appointed Vice President, Head of Global Marketing for Eisai Inc. in Woodcliff Lake, NJ;  in 2011, was appointed Vice President, Established Products Business Unit; in 2013, was appointed President & General Manager for Eisai Limited in Mississauga, ON.
  • Appointed President of BIOVECTRA Inc., December 10, 2015.
  • Board Director for BIOTECanada
  • Member of the Steering Council of Innovative Medicines Canada (IMC)
  • In 2017, appointed to the Government of Canada’s Health/Bio-sciences Strategic Economic Table
  • In November 2019, promoted to Chief Executive Officer at BIOVECTRA
  • In June 2020, named new Chair of PEI BioAlliance Board of Directors